| Schedule of Balance Sheet and Income Statement Information for Joint Ventures |
The following table provides summarized balance sheet and income statement information for Joint Ventures: | | | KC-Glory JV | | | KC-Geotech JV | | | KC-CRFG JV | | | Total | | | | | As of March 31, 2026 | | | Current assets | | $ | 1,735,185 | | | | 245,772 | | | | 1,162,731 | | | | 3,143,688 | | | Non-current assets | | | — | | | | — | | | | — | | | | — | | | Current liabilities | | | 1,426,194 | | | | 269,945 | | | | 339,130 | | | | 2,035,269 | | | Non-current liabilities | | | — | | | | — | | | | — | | | | — | | | Equity (Deficit) | | $ | 308,991 | | | | (24,173 | ) | | | 823,601 | | | | 1,108,419 | | | | | KC-Glory JV | | | KC-Geotech JV | | | KC-CRFG JV | | | Total | | | | | As of March 31, 2025 | | | Current assets | | $ | 1,748,391 | | | $ | 247,932 | | | $ | 1,188,208 | | | $ | 3,184,531 | | | Non-current assets | | | — | | | | — | | | | — | | | | — | | | Current liabilities | | | 1,436,946 | | | | 271,864 | | | | 370,751 | | | | 2,079,561 | | | Non-current liabilities | | | — | | | | — | | | | — | | | | — | | | Equity (Deficit) | | $ | 311,445 | | | $ | (23,932 | ) | | $ | 817,457 | | | $ | 1,104,970 | | | | | Year ended March 31, 2026 | | | Total revenues | | $ | — | | | | — | | | | 9,748,960 | | | | 9,748,960 | | | Net (loss)/profit | | $ | (111 | ) | | | (424 | ) | | | 12,345 | | | | 11,810 | | | | | Year ended March 31, 2025 | | | Total revenues | | $ | — | | | | 641 | | | $ | 4,828,815 | | | $ | 4,829,456 | | | Net loss | | $ | (64 | ) | | | 7,168 | | | $ | 5,443 | | | $ | 12,547 | |
|
| Schedule of Equity Method Investment in Joint Ventures |
The following table summarizes the activity of the Company’s equity method investments in joint ventures: | | | Total | | | Balance at April 1, 2024 | | $ | 1,311,010 | | | Company’s share in net profit recognized during the year | | | 5,528 | | | Exchange difference | | | 7,591 | | | Balance at March 31, 2025 | | | 1,324,129 | | | Company’s share in net profit recognized during the year | | | 4,048 | | | Exchange difference | | | (9,982 | ) | | Balance at March 31, 2026 | | $ | 1,318,195 | |
|
| Schedule of Other Investments at Fair Value on Recurring Basis |
The following table provides a reconciliation of the other investment at fair value on a non-recurring basis using significant unobservable inputs: | | | 2026 | | | 2025 | | | Balance as of March 31, 2025 | | $ | — | | | $ | — | | | Addition | | | 20,000,000 | | | | — | | | Fair value adjustment | | | 23,437,041 | | | | — | | | Exchange difference | | | (257,027 | ) | | | | | | Balance as of March 31, 2026 | | $ | 43,180,014 | | | $ | — | |
|
| Schedule of Other Investments in Equity Method Investment |
The following table provides a reconciliation of the other investment at equity method investments: | | | 2026 | | | 2025 | | | Balance as of March 31, 2025 | | $ | — | | | $ | — | | | Addition | | | 3,000,000 | | | | — | | | Exchange difference | | | (18,752 | ) | | | | | | Balance as of March 31, 2026 | | $ | 2,981,248 | | | $ | — | |
|